MISSION

  • 01
    We aim toward introducing design concepts into cardiovascular surgery and improve the reproducibility of surgery with blood flow imaging.
  • 02
    We aim toward predicting the prognosis of heart failure with blood flow imaging.
  • 03
    We aim toward revealing the cause of aortic disease, which would contribute to establishing clinical guidelines with blood flow imaging.
  • 04
    We aim toward suggesting optimal procedures and indications of congenital heart diseases with blood flow imaging.
  • 05
    We aim toward a standard diagnostic and therapeutic strategy of ischemic heart disease with blood flow imaging.

COMPANY PROFILE

  • Corporate Name
    Cardio Flow Design Inc.
  • Address
    22-3 Ichibancho, Chiyoda-ku, Tokyo
  • Postal Code
    102-0082
  • Establishment
    August, 2015
  • Business Description
    Development and Sales of Application
  • E-mail
    info@cfd.life
  • URL
    http://cfd.life
  • SNS
    

PARTNER

  • User friendly interface
    University facilities 62、Hospitals 39、Companies 21、Overseas 4
       
  
  

CORPORATE SOCIAL RESPONSIBILITY

  • Organization type
    Number of Organizations
    Total
    ¥ 2,264,820
  • Public
    University
    3
    ¥870,000
  • Private
    University
    2
    ¥515,000
  • Medical
    Centers
    3
    ¥721,000
  • Overeas
    Universities
    1
    ¥158,820
  • Updated on 1st January 2024

  • Cardio Flow Design Inc. donates half of the costs of Blood Flow Analysis to research on congenital heart disease in children.

MEMBER

  • Teruyasu Nishino
    Founder & CEO
    Teruyasu Nishino
    Medical Doctor
  • Background
    Teruyasu Nishino was born in 1976. He studied in Mayo Clinic Elective Clerkship and graduated from Juntendo University. He is a member of the Japanese orthopaedic association. He has managed variety of companies including medical company, social welfare service corporation and other corporations.
“Learn more flow, save more lives” is the corporate mission of Cardio Flow Design, and we aim for a world where medical doctors can diagnose using blood flow easily. Along with the development of IT technology, MRI, and CT, we are now able to know much more deeply about blood flow. Based on this data, we can predict possible future diseases and schedule planned surgeries in advance, which will bring significant innovation to the diagnosis and treatment of cardiovascular medicine and surgery. To make blood flow analysis become a diagnostic technology for the new generation, our team of doctors and engineers are steadily developing their blood flow analysis technology, and we believe the day it can be used for actual diagnosis is close. However, as this field can use much more research, if there is any idea regarding blood flow that can contribute to medical, please do not hesitate to contact us.
  • Shohei Miyazaki
    Chief Technology Officer
    Shohei Miyazaki
    Doctor of Philosophy
  • Background
    Shohei Miyazaki was born in 1989. He graduated from Waseda University in 2014. After that, he studied hemodynamic analysis using computational fluid dynamics and MRI at the Kitasato university. He joined Cardio Flow Design Inc. in 2015
  • Ryo Okamoto
    General Manager
    Ryo Okamoto
  • Background
    Ryo Okamoto was born in 1989. In 2012, He joined the medical corporation Hakuhokai as a medical social worker. In 2017, He joined the Medical Association Yukoukai as Secretary General.
  •  
    Chief Financial Officer
    Toru Kobayashi
  • Background
    Toru Kobayashi was born in 1991. He graduated from Kyoto University in 2014. After that, he joined Sumitomo Mitsui Banking Corporation. In 2016, he joined Interstellar Technologies Inc. as CFO. He joined Cardio Flow Design Inc. in 2024.
  • Ben Dyer
    Software Engineer
    Ben Dyer
    Doctor of Philosophy
  • Background
    Ben Dyer studied mathematics at the University of Oregon, obtaining his PhD with specialization in algebraic geometry in 2017. He has worked as a software engineer in Tokyo since 2019, and joined Cardio Flow Design Inc. in 2022. He is interested in applications of topological flow data analysis (TFDA) to understanding blood flow in the heart.
  • Kohei Suzuki
    Hemodynamic Engineer
    Kohei Suzuki
  • Background
    Kohei Suzuki was born in 1992. He graduated from Tokai University in 2015. After that, he studied at the graduate schoolof Physics at Tokai University . He joined Cardio Flow Design Inc. in 2015. He likes programming, fluid analysis, Mathematics, and Physics.
  • Kisako Takeda
    Financial Manager
    Kisako Takeda
  • Background
    Kisako Takeda worked at the tax office until 1999. She served as accounting general affairs for venture companies such as the restaurant industry, flower industry, advertising industry, and human resources industry. After that, she joined Cardio Flow Design Inc. in 2020.
  • Saksham Arya
    Lead Engineer
    Saksham Arya
  • Background
    Saksham Arya was born in 2000, and has graduated from Manipal University Jaipur, majoring in Mechanical Engineering in 2021. Always self-motivated to learn and grow with practical experience and has keen interest in fluid analysis, 3D designing and modeling, and programming. He has joined Cardio Flow Design in 2021.
  • Software Engineer
    Samuel LEUNG
  • Background
    Samuel Leung was born in 1997 and graduated from the Tokyo Institute of Technology, majoring in Mechanical Engineering in 2021. During his college years,  he focused on studying Numerical Analysis specifically Computational Fluid Dynamics and Magnetohydrodynamics. He joined Cardio Flow Design in 2023.
  • Naoya imai
    Software Engineer
    Naoya Imai
  • Background
    Naoya Imai was born in 1998. He graduated from in Tsukuba University 2021. After that, entered the graduate school of the Tokyo University. His major is mechanical engineering at the School of Engineering.
  • Office Manager
    Kyoko Fukuda
  • Background
    Kyoko Fukuda was born in 1998. She graduated from a Dental Hygienist School 2020. After that, joined Cardio Flow Design.
  • Software Engineer
    Kakeru Ito
  • Background
    Kakeru Ito was born in 2000 in Saitama Prefecture, Japan. In 2023, he graduated from the Faculty of Pharmaceutical Sciences, Department of Life Pharmaceutical Sciences, at Tokyo University of Science. Subsequently, in the same year, he enrolled in the Graduate School of Pharmaceutical Sciences at Tokyo University of Science, specializing in Pharmaceutical Science.

FOUNDER & TECHNICAL ADVISER

  • Keiichi Itatani
    Founder & Technical Adviser
    Keiichi Itatani
    Medical Doctor
    Doctor of Philosophy
    Achievement List (Japanese)PDF Old Lecture List (Japanese)PDF Wikipedia Keiichi Itatani (Japanese) External
  • Background
    Keiichi Itatani was born in 1977. He is a cardiovascular surgeon and a researcher of fluid dynamics. Since he graduated from the university of Tokyo in 2002, he has been involved in the clinical practice of cardiovascular surgery, and at the same time, has been thinking about “what the optimal cardiovascular surgery is”, and he started research of fluid dynamics in cardiology. He developed blood flow simulation method useing computational fluid dynamics (CFD), blood flow imaging with phase contrast MRI and echocardiography vector flow mapping (VFM) and he invented energy loss calculation method. He became an endowed chair, Department of Hemodynamic Analysis in Kitasato University School of Medicine in 2012. He founded Cardio Flow Design Inc in 2015, and he is working for the department of cardiovascular surgery in Kyoto Prefectural University of Medicine from 2015. He became an endowed chair of Cardiovascular Imaging Research Laboratory in Kyoto Prefectural University of Medicine in 2016. He became an adult congenital heart surgeon in Kyoto Prefectural University of Medicine in 2018. He became Hospital lecturer in the department of cardiovascular surgery in Osaka City University in 2021.He became a lecturer in cardiovascular surgery at Nagoya City University in 2022.He became an associate Professor at Nagoya City University Graduate School of Medical Sciences, Department of Cardiovascular Surgery, Director of the Adult Congenital Heart Disease Center in 2023.
Cardio Flow Design, Inc. was founded with the aim of developing the blood flow imaging, which had been an advanced research product, to an essential and practical tool and the de facto standard for cardiology and cardiovascular surgery. Blood flow imaging is a translational research field from medical science and computer technology, and we are aiming toward developing engineers and medical scientists for bridging the gap between advanced high-end research outcomes and medical practice. Our goal is to produce new medical research service tools based on flexibility outside of existing frameworks and on profound knowledge and skill on basic science, which would improve the reproducibility of diagnosis and treatment of cardiovascular diseases.